CompletedNCT02811211
Genes Related to Glutamate Signaling in Young People With ADHD
About this title
Read the official source — NCT02811211Observational studyAges 6–17United States
Understand this study
Who was this study for?
Listed age limits: 6 years to 17 years.
- Listed locations
- WilmingtonSee all locations and recruitment
Study information
Study start dateFebruary 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 1,894
- Sponsor
- Aevi Genomic Medicine, LLC, a Cerecor company
- Sponsor type
- Pharmaceutical company
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT02811211
- Official title
Show the full official title
A Noninterventional Genotype/Phenotype Study of mGluR Mutations in Children and Adolescents With Attention Deficit Hyperactivity Disorder (ADHD)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedWilmington
Questions about this study
Who is behind this study?
The study sponsor is Aevi Genomic Medicine, LLC, a Cerecor company, a pharmaceutical company.
Who was this study for?
Listed age limits: 6 years to 17 years.
